Elevated GDF15 levels correlate with advanced stages of fibrosis, suggesting that GDF15 could be used to identify patients at higher risk of progressing to severe liver diseases, including cirrhosis and hepatocellular carcinoma (42, 43). This evidence concerns the gene GDF15 and Cirrhosis.